Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data-Reference-Cited by-同舟云学术

Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data

Published:2015-12 Issue:16 Volume:16 Page:1639-1650
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Meulendijks Didier,Henricks Linda M,Sonke Gabe S,Deenen Maarten J,Froehlich Tanja K,Amstutz Ursula,Largiadèr Carlo R,Jennings Barbara A,Marinaki Anthony M,Sanderson Jeremy D,Kleibl Zdenek,Kleiblova Petra,Schwab Matthias,Zanger Ulrich M,Palles Claire,Tomlinson Ian,Gross Eva,van Kuilenburg André B P,Punt Cornelis J A,Koopman Miriam,Beijnen Jos H,Cats Annemieke,Schellens Jan H M

Publisher

Elsevier BV

Subject

Oncology

Reference47 articles.

1. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

2. Severe toxicity related to the 5-fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients;Tsalic;Am J Clin Oncol,2003

3. Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women;Bajetta;J Clin Oncol,2005

4. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors;Lévy;J Clin Oncol,1998

5. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil;Van Kuilenburg;Eur J Cancer,2004

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD;Genome Medicine;2024-08-15

2. MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy;International Journal of Molecular Sciences;2024-08-04

3. Relationship Between Dihydropyrimidine Dehydrogenase Gene Polymorphism and Toxicities in Cancer Patients Receiving 5-Fluorouracil;Forbes Journal of Medicine;2024-08-01

4. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

5. Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study;Pharmaceutics;2024-07-19